April 25, 2024
Market Now
Celltrion inks W176b deal with affiliate
[DISCLOSURE] Celltrion (068270) announced on Dec. 28 that it has signed a 176.0 billion won (US$158.13 million) contract with its affiliate Celltrion Healthcare (091990) to supply biosimilar antibody Herzuma.
This amounts to 18.54 percent of its 2017 revenue and the contract is valid until Dec. 31.
By Hwang You-mee (glamazon@heraldcorp.com)
This amounts to 18.54 percent of its 2017 revenue and the contract is valid until Dec. 31.
By Hwang You-mee (glamazon@heraldcorp.com)
![[KH Explains] Korean shipbuilding stocks rally: Real growth or bubble?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2024/04/25/20240425050656_0.jpg)
![[Hello India] Hyundai Motor vows to boost 'clean mobility' in India](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2024/04/25/20240425050672_0.jpg)
